ViaLase®
News

Check back here for the latest updates on our research and clinical studies, as well as industry coverage about the ViaLuxe Laser System.

1 2
July 30, 2024  |  Press Release

ViaLase Receives CE Mark for First Femtosecond Laser for the Treatment of Glaucoma, the ViaLase® Laser

Read More
April 1, 2024  |  Press Release

ViaLase Closes $40 million Series C Financing to Advance First Femtosecond Laser for the Treatment of Glaucoma

Read More
October 30, 2023  |  Press Release

ViaLase Completes Enrollment for the Pivotal VIA-002 Trial of the ViaLase® Laser to Treat Primary Open Angle Glaucoma

Read More
May 30, 2023  |  Press Release

ViaLase to Present Clinical Data at the 2023 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting

Read More
April 18, 2023  |  Press Release

ViaLase to Present New Scientific Data at the 2023 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

Read More
April 18, 2023  |  Press Release

Vialase Announces Publication of 24-Month Safety Data from First-in-Human Study of Femtosecond Laser Image-Guided High-Precision Trabeculotomy (FLigHT)

Read More
ViaLase Inc.
Skip to content